Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus
Filetype[PDF-1.05 MB]


Details:
  • Alternative Title:
    PLoS Negl Trop Dis
  • Personal Author:
  • Description:
    Ebola virus (EBOV) infection in humans and non-human primates (NHPs) is highly lethal, and there is limited understanding of the mechanisms associated with pathogenesis and survival. Here, we describe a transcriptomic analysis of NHPs that survived lethal EBOV infection, compared to NHPs that did not survive. It has been previously demonstrated that anticoagulant therapeutics increase the survival rate in EBOV-infected NHPs, and that the characteristic transcriptional profile of immune response changes in anticoagulant-treated NHPs. In order to identify transcriptional signatures that correlate with survival following EBOV infection, we compared the mRNA expression profile in peripheral blood mononuclear cells from EBOV-infected NHPs that received anticoagulant treatment, to those that did not receive treatment. We identified a small set of 20 genes that are highly confident predictors and can accurately distinguish between surviving and non-surviving animals. In addition, we identified a larger predictive signature of 238 genes that correlated with disease outcome and treatment; this latter signature was associated with a variety of host responses, such as the inflammatory response, T cell death, and inhibition of viral replication. Notably, among survival-associated genes were subsets of genes that are transcriptionally regulated by (1) CCAAT/enhancer-binding protein alpha, (2) tumor protein 53, and (3) megakaryoblastic leukemia 1 and myocardin-like protein 2. These pathways merit further investigation as potential transcriptional signatures of host immune response to EBOV infection.

  • Subject:
  • Document Type:
    Journal Article
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. Transcriptomics Reveal Antiviral Gene Induction in the Egyptian Rousette Bat Is Antagonized In Vitro by Marburg Virus Infection
    Personal Author:
    Arnold, Catherine E.; Guito, Jonathan C.; Altamura, Louis A.; Lovett, Sean P.; Nagle, Elyse R.; Palacios, Gustavo F.; Sanchez-Lockhart, Mariano; Towner, Jonathan S.;
    Published Date:
    Nov 02 2018
    Source:
    Viruses. 2018; 10(11)
    Description:
    The Egyptian rousette bat (ERB) is the only known Marburg virus (MARV) reservoir host. ERBs develop a productive MARV infection with low viremia and shedding but no overt disease, suggesting this virus is efficiently controlled by ERB antiviral respo...
    File Type:
    Filetype[PDF - 1.89 MB]
  2. Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses
    Personal Author:
    Albariño, César G.; Wiggleton Guerrero, Lisa; Chakrabarti, Ayan K.; Nichol, Stuart T.;
    Published Date:
    Aug 02 2018
    Source:
    PLoS One. 13(8).
    Description:
    Filoviruses are notorious viral pathogens responsible for high-consequence diseases in humans and non-human primates. Transcription of filovirus mRNA shares several common features with transcription in other non-segmented negative-strand viruses, in...
    File Type:
    Filetype[PDF - 2.22 MB]
  3. A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
    Personal Author:
    Flint, Mike; Chatterjee, Payel; Lin, David L.; McMullan, Laura K.; Shrivastava-Ranjan, Punya; Bergeron, Éric; Lo, Michael K.; Welch, Stephen R.; Nichol, Stuart T.; Tai, Andrew W.; Spiropoulou, Christina F.;
    Published Date:
    January 17 2019
    Source:
    Nat Commun. 10
    Description:
    There are no approved therapies for Ebola virus infection. Here, to find potential therapeutic targets, we perform a screen for genes essential for Ebola virus (EBOV) infection. We identify GNPTAB, which encodes the α and β subunits of N-acetylgluc...
    File Type:
    Filetype[PDF - 1.75 MB]
  4. A New Approach for Monitoring Ebolavirus in Wild Great Apes
    Personal Author:
    Reed, Patricia E.; Mulangu, Sabue; Cameron, Kenneth N.; Ondzie, Alain U.; Joly, Damien; Bermejo, Magdalena; Rouquet, Pierre; Fabozzi, Giulia; Bailey, Michael; Shen, Zhimin; Keele, Brandon F.; Hahn, Beatrice; Karesh, William B.; Sullivan, Nancy J.;
    Published Date:
    Sep 18 2014
    Source:
    PLoS Negl Trop Dis. 2014; 8(9).
    Description:
    BackgroundCentral Africa is a “hotspot” for emerging infectious diseases (EIDs) of global and local importance, and a current outbreak of ebolavirus is affecting multiple countries simultaneously. Ebolavirus is suspected to have caused recent dec...
    File Type:
    Filetype[PDF - 1.00 MB]
  5. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.
    Personal Author:
    Georges-Courbot, M. C.; Sanchez, A.; Lu, C. Y.; Baize, S.; Leroy, E.; Lansout-Soukate, J.; Tévi-Bénissan, C.; Georges, A. J.; Trappier, S. G.; Zaki, S. R.; Swanepoel, R.; Leman, P. A.; Rollin, P. E.; Peters, C. J.; Nichol, S. T.; Ksiazek, T. G.;
    Published Date:
    1997 Jan-Mar
    Source:
    Emerg Infect Dis. 3(1):59-62.
    Description:
    Three outbreaks of Ebola hemorrhagic fever have recently occurred in Gabon. Virus has been isolated from clinical materials from all three outbreaks, and nucleotide sequence analysis of the glycoprotein gene of the isolates and virus present in clini...
    File Type:
    Filetype[PDF - 259.83 KB]